Absalom, A. R., Lee, M., Menon, D. K., Sharar, S. R., De Smet, T., Halliday, J., ...
Background Healthy volunteers received low-dose target-controlled infusions (TCI) of ketamine controlled by the Domino model while cognitive function tests and functional neuroimaging were performed....
Honey, G.D., Honey, R.A.E., Sharar, S.R., Turner, D.C., Pomarol-Clotet, E., Kumaran, D., ...
Rationale The precise nature of the impact of the N-methyl-d-aspartate antagonist, ketamine, upon human episodic memory, has yet to be elucidated fully. Objectives This study sought to assess the...
Honey, G.D., Honey, R.A.E., O'Loughlin, C., Sharar, S.R., Kumaran, D., Suckling, J., ...
The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine produces episodic memory deficits. We used functional magnetic resonance imaging to characterize the effects of ketamine on frontal and...
Honey, G.D., Honey, R.A.E., O'Loughlin, C., Sharar, S.R., Kumaran, D., Suckling, J., ...
The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine produces episodic memory deficits. We used functional magnetic resonance imaging to characterize the effects of ketamine on frontal and...
Honey, G.D., Honey, R.A.E., O'Loughlin, C., Sharar, S.R., Kumaran, D., Suckling, J., ...
The N-methyl-D-aspartate (NMDA) receptor antagonist ketamine produces episodic memory deficits. We used functional magnetic resonance imaging to characterize the effects of ketamine on frontal and...